Fifiiiffet Cell Numbers(1X106)

Fifiiiffet Cell Numbers(1X106)

US 20180353544A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2018/ 0353544 A1 REZVANI et al. (43 ) Pub . Date : Dec . 13 , 2018 ( 54 ) METHODS OF TREATMENT WITH Publication Classification NATURAL KILLER CELLS MATCHED FOR (51 ) Int . Ci. KILLER IMMUNOGLOBULIN RECEPTOR A61K 35 / 17 (2006 . 01 ) TYPE A61P 35 / 02 ( 2006 .01 ) CO7K 14 / 725 ( 2006 . 01 ) (71 ) Applicant: Board of Regents , The University of COZK 14 / 47 ( 2006 . 01 ) Texas System , Austin , TX (US ) CO7K 14 / 705 (2006 .01 ) CO7K 16 / 28 (2006 .01 ) ( 72 ) Inventors: Katy REZVANI, Houston , TX (US ); A61P 37706 ( 2006 .01 ) Elizabeth SHPALL , Houston , TX (52 ) U . S . CI. ( US ) ; Enli LIU , Houston , TX (US ) CPC .. .. .. .. A61K 35 / 17 ( 2013 . 01 ) ; A61P 35 / 02 (2018 . 01 ) ; CO7K 14 / 7051 (2013 .01 ) ; CO7K ( 73 ) Assignee : Board of Regents , The University of 14 / 4748 ( 2013 .01 ) ; A61K 31 /4525 ( 2013 .01 ) ; Texas System , Austin , TX (US ) CO7K 16 / 28 ( 2013 .01 ) ; A61P 37 /06 ( 2018 . 01 ) ; A61K 2300 / 00 ( 2013 .01 ) ; C07K 14 /70521 (21 ) Appl. No. : 15 /579 ,330 (2013 . 01) Jun . 6 , 2016 ( 57 ) ABSTRACT ( 22 ) PCT Filed : The present invention concerns methods of treating a disease ( 86 ) PCT No. : PCT/ US16 / 36024 such as leukemia in a subject by administering natural killer (NK ) cells . In particular aspects , HLA -C1 - licensed $ 371 ( c ) ( 1 ) , KIR2DL2 / 3 and KIR2DS2 NK cells are administered to a ( 2 ) Date : Dec . 4 , 2017 subject with an HLA - C genotype either homozygous or heterozygous for the C1 allele, or HLA - C2 licensed cells are administered to a subjectwith an HLA - C genotype homozy Related U . S . Application Data gous for the C2 allele . In further aspects , the NK cells are (60 ) Provisional application No. 62/ 171, 520 , filed on Jun . genetically modified to express a chimeric antigen receptor 5 , 2015 . and interleukin 15 . NT- NK CELLNUMBERS(1X106) FIFIIIFFET * CAR -NK TI wwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwwww 1 3 7 9 14 22 25 DAYS IN CULTURE Patent Application Publication Dec . 13 , 2018 Sheet 1 of 41 US 2018 /0353544 A1 DAY44+CAR CAR- 99.8%0238 0103104105 CAR-+ 11.8%882 0103104105 647-A:CAR 647-A:CAR COMP-ALEXAFLUOR GEREKESKKKK yor COMP-ALEXAFLUOR Ñ og aof CD56 :A - Cy7 - PE- COMP A- Cy7 - PE- COMP wy CAR+ 87.6% DAY30 CARECAR 98.9%106 Ronymouspepenegro 0103104105 1 0103104105 COMP-ALEXAFLUOR 647-A:CAR EXITETET 647-A:CAR CAR- 12.4% pornoa COMP-ALEXAFLUOR 3830 o CD56 :A - Cyr - PE - COMP A- Cy7 - PE - COMP CAR+ 0.426% CAR+ %80.5 DAY24 0103104105 647-A:CAR 0103104105 CAR- 99.6% 647-A:CAR COMP-ALEXAFLOUR CAR- 135%. COMP-ALEXAFLUOR wy ã ã cã ZA Ž og CAR FIG.1A CD56 :: A - Cy7 - PE- COMP A- Cy7 - PE- COMP ga CAR+ CAR+ 13.2%867 0103104105 DAY18 99.8%0147 wwWMWWWWW 0103104105 647-A:CAR w COMP-ALEXAFLUOR647-A:CAR porooropp COMP-ALEXAFLUOR TAI 105G 4105A -07 - PE - COMP CD :: A -CV7 9103- PE - COMP CAR-NKS+15.2%848 0103104105 DAY10 CAR-NKS+ 99.2%0832 0103104105 647-A:CAR foresega COMP-ALEXAFLUOR 647-A:CAR COMP-ALEXAFLUOR za a V CD56 : A- 20 _ 605 BV605- COMP CD5: : A- 20 _ 605 BV605- COMP CD56 NT-NK CAR-NK Patent Application Publication Dec . 13 , 2018 Sheet 2 of 41 US 2018 /0353544 A1 KIR2DL2/ DL3 KIR2DL1 NKG2A NKP30 NKP44 NKP46 EXPANDED who AINER EXPANDEDCB NK LAUKUengelsk EXPANDED matematicaTenim ? ?? . ?? ? ?? ?? nagrangengnum ?? FIG . 1B 8 - II - I - . IR - L ILIRIPAISII KARAREASAAREMAA tem . 8 . & IIII %OFMAX man,www. wwwwww 9 mbiwakiwthornkommitmentwmillionthantuntumaanluonastirumbautinnollisteniwathamining wachawinanong 828o WOWANIU It commamontandohommeSimone & wpCWM o Set XXXXXXX 0 102 103 104 105 0 102 103 104 105 <ALEXA FLUOR 647 - A > < ALEXA FLUOR 647- A > O SOTYPE CONTROL ISOTYPE CONTROL 13 BASELINE BASELINE D D14 EXPANSION Q D14 EXPANSION ARE WLL T -BET FIG . 10 w wwwwwwwwwwwwwwwwwwwww NT- NK CELLNUMBERS(1X106) * CAR -NK ALPALOPATINIUPA1I111. 22 WWWWA 17.222 WWW - - 1 dok 3 owdown7 wwwwwwwwww9 14 22 25 DAYS IN CULTURE FIG . 1D Patent Application Publication Dec . 13 , 2018 Sheet 3 of 41 US 2018 /0353544 A1 C BASELINE hog inimo ' WWE O 025 ,upongyoogops osobigassetoolguisto nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnnn insiantis EXPANSION EOMES T -BET KLRG1 FIG . 1E NEG CONTROL K562 Raji LS2 CAR+ winnnnnnnnnnnnn 900 % -102 8. 6 % 12. 2 % CD56 RaRozga1020 103 104 105 1020 103 104 105 102 1 103 104 105 CAR www Entre -1022 5 .0 % -102 - 102 103 104 105 - 102 103 104 105 -102 103 104 105 IFN -2 FIG . 1F Patent Application Publication Dec . 13 , 2018 Sheet 4 of 41 US 2018 /0353544 A1 PERFORIN PHALLOIDIN CAR FIG . 1G NON - TRANSDUCED NK CAR - TRANSDUCED- 1212NK WORLIKE 1 MAR WAMAWAMAMAWAMAMAMAKKAAMMWMMWANAWAKAKAWAWALALALALALAMIKAMAMMWMMMM.MAU SISA7% NESSA porte SISA7% en comm WWWWWWWY wwwwwwwwwwwwwwwwwwwwwwwwwww e nt RATIO 20 : 1 RATIO 10 : 1 RATIO 5 : 1 RATIO 1 : 1WWWwwwwww FREAK RATIO 20: 1 RATIO 10: 1 RATIO 5: 1RATIO 1: 1 WWWWWWWWWWW EFFECTOR :TARGET RATIO EFFECTOR :TARGET RATIO K562 W WARTO RAJI + * F * CLL FIG . 1H1 WEB Patent Application Publication Dec . 13 , 2018 Sheet 5 of 41 US 2018 /0353544 A1 wwy - NO REVLIMID * nnnnnnnnnnnnnnnnnnn - - PLUS REVLIMD nnnnnnnnnnnnnnnnnnnnn P < 0 .001 AT 1 : 1 AND 10 : 1 PERCENTSPECIFICLYSIS oö83 ???????????????????? E :T RATIO nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn FIG . 11 Patent Application Publication Dec . 13 , 2018 Sheet 6 of 41 US 2018 /0353544 A1 U? Day 9 FIG2000 . 2A WWWWWWWWW HINA FIG . 2B Patent Application Publication Dec . 13 , 2018 Sheet 7 of 41 US 2018 /0353544 A1 CD16+ 92.2% CD16+pwr94.1% COMP-BV650660_20A:CD16 MMMMM Anwwwwwwwwwwwwww WWWWWWWWWW pornograpynagog 1051041030 via 103 COMP-AlexaFluor647A:CARBV650660_20CD16 A- Cy7 - PE- COMP 10510410301051041030 A- Cy7 - PE- COMP CAR+96.7% myCARto- COMP-AlexaFluor647A:CAR CAR torpoowwwporn 4.37%956 power20105 104103 0 Alexa-MP 1031 A- CY7- PE- COMP A- CY7 - PE -COMP * wwwwwwwwrope COMP-APCH7A:CD3 COMP-APCH7A:CD3 NK$ w 1051041030 *105104 1030 LAN111 WW FIG.2C 62.8% 86.5% * NKS+ * INKS ???? ????? ???????????? wwwwwwwwww wy Z 23 CD56 :A - Cy7- PE - COMP CD56 : A- Cy7 -PE - COMP wwwwwwwwwww CD19+ 0.045% CD19+0.029% 0103104105 103104105 CD19 COMP-PEA:CD19 COMP-PEA:CD19 mogymegenwowwwwwwwwwww 4 . 1 . 21 0 50K ok o 250K200K 150K$ 100K 250K A - SSC 1 MMALMX hCD45+ +hCD45 94.5% mon 98.5%MA .MALHULAAMK WWWWWW OlenkovouhudownicaSantos0103104105 COMP-PerCPeFluor710A:hCD45 0103104105 wwwwwwwwwwwwlhacinandodh COMP-PerCPeFluor710A:hCD45 ??og A- SSC A- SSC BLOOD Patent Application Publication Dec . 13 , 2018 Sheet 8 of 41 US 2018 /0353544 A1 CD16+1 CD16+ 89.2% 97.1% COMP-BV650660_20A:CD16 0103104105 COMP-BV65066020A:CD16 CD16 0103104105 AG?NUGERAGONÈSaGdawathuling P ago 2 % 3 A- Cy7- PE- COMP A- Cy7 - PE- COMP COMP-AlexaFLUOR647A:CAR 10.2%-898 0103104105 COMP-AlexaFLUOR647ACAR CAR-_CAR+ 0103104105 CAR-ht1051P ???????????? 8 $ 30 Ž à A- Cy7- PE - COMP A -C7 - PE- COMP SUV4444 ol NKS+ 83.7% NKS COMP-APCH7A:CD3 INKS COMP-APCH7A":CD3 agai105 1041030 0103104105 FIG.2CCont wingpoonop OUR 852 o CD56 :: A - CY7- PE - COMP CD56 : A- Cy7 - PE- COMP 1051041030 COMP-PEA:CD19 0103104105 COMP-PEA:CD19 CD19+ 0.025% +CD19250K onangpangunan 250K 50K 200K SSCA SSCA wawasanbCD45+1 82.6% 99.8% A . 1051041030 11 0103104105 hCD45 persvoor COMP-PerCPeFluor710A:hCD45 COMP-PerCPeFluor710A.HCD45 150K100K 50K 250K 50K A- SSC BONEMARROW N Patent Application Publication Dec . 13 , 2018 Sheet 9 of 41 US 2018 /0353544 A1 w CD16+96.4% COMP-BV650 36020-A:CD16 hCD16 2 & 3lakritsi A. Cy7- PE - COMP 923% COMP-ALEXA FLUOR647-A:CAR ]+CAR-LCAR CAR ISBL ???????????????????????????????? C77A- PE- COMP 87.2% COMP-APCH7A:CD3 NKS immbarenetahonetaneresuntdisheshorelowaniskaElbasaurshakurye hCD3 PXL12 . 119 Ž a FIG.2D CD56= A - Cy7 - PE - COMP CD19+0.080% COMP-PEA:CD19 32322 hCD19 LIISIUNI 250KT200K A- SSC hCD45+ COMP-PerCPeFLOUR710-A:hCD45 240% hCD45 tinkantistatiškistanbulrinktiniai 250K A- SSC Patent Application Publication Dec . 13, 2018 Sheet 10 of 41 US 2018 /0353544 A1 PRATHATHURTHITHERITA SR)/CM2SEC/(P RADIANCE MIN=4,00e5 MAX=7.00e6 0.6- |4.0100 -20 COLORSCALE DAWC Min ROLEROI23ROT3=47R014-2.901e605 CAR-NKS+RajiFFLUC 952RolROMROI15-2.RO 229922 99999999999pg999popoyoooops 02299 EL20141203164938A2. EL20141210100130A EL20141217102054A FIG.2E 2033.47RONROI o NT-NKS+RajiFFLUC ROI18IROI1718|RO1920-3085051IRO12TRO13TROI14TRO153.238e5FIRO2TROI=532739e45 0922 o 222227) ooooo ROJF2R012-RO13=R0148RO1519112H00ROTEROTRO141.707e+05 250 EL20141203170501A EL20141210102001A EL20141217103640Aooooooooooooooooooooooooo ROTTRO008-ROROOTROT1033.RO17ROTO Raji-FFLUCONLY ograd ooo EL20141203163752AOOOOooooooooo IEL20141210094507AWysyyyyyy999 EL20141217100737Ao DAYO DAY7 DAY14 Patent Application Publication Dec . 13, 2018 Sheet 11 of 41 US 2018 /0353544 A1 (PISEC/CM2ISR) RADIANCE COLORSCALE MIN=4.00e5 MAX=7.00e6 ||4.0x108 -20 wwwwww W 058102-.2=FLRO1ROL R015-ROI6=23,519e05 139e05ROI-2.ROLE CAR-NKs+RajiFFLUC IEL20141224100521A IEL20150107104806A* kwkwkwkwkwkwk FIG.2F NT-NKs+Raji ROI3-7.425€+05 FFLUC RO-89RON102832e175 you RO16=ROIZEROTERO9:ROI104232e107ERO12RO13R014R0151.0008-06 EL20141224005216A EL20141230103558A EL20150107103637A RAJ.-FFLUC ONLY EL20141224099954A ROI2=8.04ROISROT4834812+08 EL20141230101648A DAY21 DAY28 DAY35 Patent Application Publication Dec . 13, 2018 Sheet 12 of 41 US 2018 /0353544 A1 800? ? 6000 2000| - - - - - FIG* . 2G Percentsurvival - - - - - - - - - - ??? Days FIG . 2H Patent Application Publication Dec . 13, 2018 Sheet 13 of 41 US 2018 /0353544 A1 NT - NO AP1903 NT + AP1903 n 10. 8 % + 9 .5 % Ž Ž waliolewekiherkku Uuuuuuuuuuuuuuuuuuuuuuuu manbusbbwbannhanhnikenakannbundns3ssohnnkakshassland

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    61 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us